SAIPARENT news

• 01-Nov-2026 16:11:50

  SAIPARENT Q2 : CONS NET PROFIT UP 65.5% AT ₹10.51 CR (YOY), UP 32.7% (QOQ). STRONG (ON 1ST LOOK)

  • Revenue up 262.5% at ₹194.02 Cr (YOY), up 8.6% (QOQ). • EBITDA up 244.6% at ₹43.96 Cr (YOY), up 61.3% (QOQ); margins 22.7% v 23.8% (YOY), 15.3% (QOQ). • Basi…

• 01-Nov-2026 15:41:21

  SAI PARENTERALS Q2 FY27 (CONS.) ; NET PROFIT UP 65.51% AT ₹10.51 CR (YOY), UP 32.65% (QOQ)

  REVENUE UP 264.14% AT ₹194.92 CR (YOY), UP 9.09% (QOQ) EBITDA UP 252.32% AT ₹40.24 CR (YOY), UP 71.10% (QOQ) MARGINS AT 20.65% VS 21.34% (YOY), 13.16% (QOQ)

• 01-Nov-2026 15:00:16

  SATPARENT Q2 : CONS NET PROFIT UP 65.5% AT ₹10.51 CR (YOY), UP 32.6% (QOQ)

  • Revenue up 262.5% at ₹194.02 Cr (YOY), up 8.6% (QOQ). • PBT up 8.0% at ₹9.89 Cr (YOY), up 1.0% (QOQ). • PAT margin 5.4% vs 11.9% (YOY) and 4.4% (QOQ). Impact…

• 05-Oct-2026 15:44:20

  SAI PARENTERALS: MUMBAI STEP-DOWN SUBSIDIARY ACQUIRES 60% EQUITY STAKE OF PRATHYAK LABORATORIES

  • Sai Parenterals Limited completes the acquisition of 60% equity stake in Prathyak Laboratories Private Limited for Rs. 15 crore. • Prathyak Laboratories, an…

• 30-Sept-2026 12:03:28

  SAI PARENTERALS : RESIGNATION OF COMPANY SECRETARY AND APPOINTMENT OF NEW OFFICERS

  • Ms. Shivali Aggarwal resigned as Company Secretary & Compliance Officer, effective September 30, 2026. • Mr. Ashwani Singh Bisht appointed as Company Secreta…

• 25-Aug-2026 18:43:18

  SAI PARENTERALS : AUSTRALIA STEP-DOWN SUBSIDIARY ACQUIRES 100% SHARES OF LEADING PHARMACY NETWORK

  SAI PARENTERALS : AUSTRALIA STEP-DOWN SUBSIDIARY ACQUIRES 100% SHARES OF LEADING PHARMACY NETWORK

• 01-Jul-2026 16:36:39

  SAI PARENTERALS : SECURES OTC MEDICINE SUPPLY AGREEMENT WORTH OVER RS 1300 CRORES

  • Sai Parenterals Limited subsidiary Noumed Pharmaceuticals Pty Limited entered OTC medicines Supply Agreement with Australia's leading pharmacy network. • Con…

← Back to feed